Clinical trial
Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors
NCT00112892 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00112892 |
|---|---|
| Title | Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I and Pharmacokinetic Study of Selenomethionine With Fixed Dose Irinotecan in Advanced Solid Tumors |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Dietary Supplement, Drug |
| Interventions | selenium, irinotecan hydrochloride |
| Enrollment | 36 |
| Start date | Aug 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jun 3, 2005 |
| Last update posted | Jan 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: